Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe
Transplant International · 2024
DOI: 10.3389/ti.2024.13705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Maddalena Peghin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-Azienda Socio Sanitaria Territoriale (ASST)-Sette L…. Hauptthemen laut MEDLINE: COVID-19, Tissue Donors, SARS-CoV-2, Organ Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
SARS-CoV-2 infection represents a new challenge for solid organ transplantation (SOT) with evolving recommendations. A cross-sectional survey was performed (February–June 2024) to describe practices among Member States of the Council of Europe (COE) on the use of organs from deceased donors with resolved or active SARS-CoV-2 infection. Overall, 32 out of 47 Member States with a transplant program participated in the study. Four (12.5%) countries did not use organs from deceased donors either with resolved or with active SARS-CoV-2 infection and 8 (25%) countries accepted organs only from deceased donors with resolved SARS-CoV-2 infection. Donor evaluation for SARS-CoV-2 included universal screening with standard PCR testing on respiratory specimens generally (61.4%) performed within 24 h prior to organ recovery. Further microbiological, immunological and radiological investigations varied. Most waitlisted patients receiving organs from a deceased donor with active (94.5%) or resolved (61.5%) SARS-CoV-2 infection were preferred to have natural, vaccine-induced or hybrid SARS-CoV-2 immunity. Most countries did not require recipients to undergo specific anti-SARS-CoV-2 treatment as pre-exposure (0%), post-exposure prophylaxis (15.4%) or modification of immunosuppression regimen (24%). This study highlights similarities and heterogeneities in the management of SARS-CoV-2 positive donors between COE countries, and a potential to safely expand donors’ pool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-Azienda Socio Sanitaria Territoriale (ASST)-Sette Laghi, Varese, Italy.
- Division of Medical Statistic, Department of Medicine, University of Udine, Udine, Italy.
- European Directorate for the Quality of Medicines and HealthCare (EDQM), Strasbourg, France.
- Italian National Center for Transplantation (CNT), Rome, Italy.
- Organización Nacional de Trasplantes, Ministerio de Sanidad, Madrid, Spain.
Zitieren
APA
Peghin, M., Graziano, E., De Martino, M., Balsamo, M. L., Isola, M., López-Fraga, M., Cardillo, M., Feltrin, G., Domínguez-Gil González, B., Grossi, P. A., & COVIDonors COE Study Group (2024). Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe. Transplant International. https://doi.org/10.3389/ti.2024.13705
Vancouver
Peghin M, Graziano E, De Martino M, Balsamo ML, Isola M, López-Fraga M, et al. Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe. Transplant International. 2024. doi:10.3389/ti.2024.13705
BibTeX
@article{Peghin2024,
author = {Peghin, Maddalena and Graziano, Elena and De Martino, Maria and Balsamo, Maria Luisa and Isola, Miriam and López-Fraga, Marta and Cardillo, Massimo and Feltrin, Giuseppe and Domínguez-Gil González, Beatriz and Grossi, Paolo Antonio and COVIDonors COE Study Group, COVIDonors COE Study Group},
title = {Acceptance of Organs from Deceased Donors With Resolved or Active SARS-CoV-2 Infection: A Survey From the Council of Europe},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.13705}
}
EUVIMED